Development and validation of a novel prognostic and for osteosarcoma patients utilizing multiple organelle related genes
Bing Sun, Jieyang Zhu, Yi Jiang, Sihui Chen, Tao Zhang · 2026
Read Development and validation of a novel prognostic and for osteosarcoma patients utilizing multiple organelle related genes by Bing Sun, Jieyang Zhu, Yi Jiang, Sihui Chen, Tao Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13507021.txt.
Description
Bing Sun, Jieyang Zhu, Yi Jiang, Sihui Chen, and Tao Zhang build, in 2026 work, a survival forecast for osteosarcoma based on genes tied to cell organelles. Osteosarcoma is the most common malignant bone tumor, often seen in teens. The team screened gene data from patient cohorts and kept three genes linked to outlook: ACSS2, CLTCL1, and PLD3.
Their three-gene score divided the cohort into high-risk and low-risk groups whose survival differed clearly, and it held up in a second cohort. Risk groups also differed in response to four drugs in lab data. Cell tests supported a real role for ACSS2 in tumor behavior. The score could help sort patients and point to new treatment targets.
Catalog record
| CREATOR | Bing Sun, Jieyang Zhu, Yi Jiang, Sihui Chen, Tao Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28514 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |